Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204

LESSONS LEARNED: The 5-year oncologic outcomes from the trial regimen were excellent. However, the neoadjuvant and surgical toxicity of this regimen was significant and was the primary reason for the low compliance with adjuvant systemic therapy. Due to the lack of an improvement in the pathologic c...

Szczegółowa specyfikacja

Zapisane w:
Opis bibliograficzny
Wydane w:Oncologist
Główni autorzy: Landry, Jerome C., Feng, Yang, Prabhu, Roshan S., Cohen, Steven J., Staley, Charles A., Whittington, Richard, Sigurdson, Elin Ruth, Nimeiri, Halla, Verma, Udit, Benson, Al Bowen
Format: Artigo
Język:Inglês
Wydane: AlphaMed Press 2015
Hasła przedmiotowe:
Clinical Trial Results
Dostęp online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4571787/
https://ncbi.nlm.nih.gov/pubmed/25926352
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0106
Etykiety: Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!

Podobne zapisy